Best supportive care (BSC)
Showing 1 - 25 of >10,000
MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Placebo for Oral Azacitidine
-
Buenos Aires, Argentina
- +1 more
Aug 1, 2022
Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)
Recruiting
- Mast Cell Activation Syndrome
- Masitinib 4.5 mg/kg/day
- +3 more
-
Weldon Spring, Missouri
- +1 more
Jul 18, 2022
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)
Active, not recruiting
- Carcinoma, Hepatocellular
- pembrolizumab
- +2 more
-
Hefei, Anhui, China
- +40 more
Mar 3, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (capecitabine, Best supportive care (BSC))
Completed
- Nasopharyngeal Carcinoma
- capecitabine
- Best supportive care (BSC)
-
Guangzhou, Guangdong, ChinaSunYat-senU
Jul 30, 2020
Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Covid19 Trial in Mumbai, New Delhi (Itolizumab IV infusion, Best
Completed
- Acute Respiratory Distress Syndrome
- +2 more
- Itolizumab IV infusion
- Best supportive care (BSC)
-
Mumbai, India
- +3 more
Jun 10, 2021
Hepatocellular Carcinoma Trial (biological, drug, other)
Completed
- Hepatocellular Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Aug 30, 2022
Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)
Recruiting
- Melanoma
- OH2
- Salvage chemotherapy or best supportive care
-
Beijing, Beijing, China
- +2 more
May 11, 2023
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Platinum-sensitive Ovarian Cancer
- Relapsed Ovarian Cancer
- OSE2101
- Pembrolizumab 25 MG/ML [Keytruda]
-
Angers, France
- +27 more
Jul 25, 2022
Anemia Trial in Worldwide (biological, drug, other)
Recruiting
- Anemia
- Luspatercept
- +2 more
-
Halifax, Nova Scotia, Canada
- +11 more
Jan 3, 2023
Bone Sarcoma, Osteosarcoma Trial in France (Treatment by regorafenib and best supportive care, Treatment by and best supportive
Recruiting
- Bone Sarcoma
- Osteosarcoma
- Treatment by regorafenib and best supportive care
- Treatment by placebo and best supportive care
-
Besançon, France
- +13 more
May 12, 2022
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- [177Lu]Lu-PSMA-617
- +2 more
- (no location specified)
Jan 2, 2023
Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))
Active, not recruiting
- Leukemia
- Azacitidine (AZA) Days 1 - 3
- +3 more
-
Tampa, Florida
- +5 more
Jul 21, 2020
Colorectal Cancer Trial in China (fruquintinib, )
Low Anterior Resection Syndrome Trial in Vilnius (Transanal irrigation, Best supportive care)
Recruiting
- Low Anterior Resection Syndrome
- Transanal irrigation
- Best supportive care
-
Vilnius, LithuaniaNational Cancer Institute
Jun 27, 2023
Feasibility of Best Supportive Care Delivery Trial (Best Supportive Care Checklist)
Completed
- Feasibility of Best Supportive Care Delivery
- Best Supportive Care Checklist
- (no location specified)
Feb 27, 2020
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte, Lancaster, Upland (Best Practice, Comprehensive
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Best Practice
- +5 more
-
Duarte, California
- +2 more
Aug 28, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Supportive Care, Survey
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Best Practice
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 17, 2023
Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best
Completed
- Advanced NET of GI Origin
- +2 more
- Everolimus
- +2 more
-
La Jolla, California
- +96 more
Jul 13, 2021
Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)
Recruiting
- Acute Myeloid Leukemia
- Oral Azacitidine
- Placebo
-
Nagoya, Aichi, Japan
- +30 more
May 25, 2022
Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:
Active, not recruiting
- Urothelial Cancer
- Avelumab
- +2 more
-
Aurora, Colorado
- +370 more
Oct 24, 2022